Amgen’s acquisition of Dark Blue Therapeutics adds a first-in-class leukemia program that aligns with the company’s growing ...

The deal hands Amgen a drug that destroys two proteins known to drive certain types of acute myeloid leukemia, a profile that ...

Dark Blue Therapeutics ("Dark Blue"), a discovery and development biotech company pioneering the next generation of precision oncology medicines, has been acquired by Amgen (NASDAQ: AMGN).

In what is thought to be the first major pharma M&A deal of the year, Amgen has bought Oxford, UK-based biotech Dark Blue ...

DUBAI, United Arab Emirates--(BUSINESS WIRE)--Alpha Blue Ocean, a family office founded by Pierre Vannineuse and a pioneer in alternative finance in Europe, is pleased to announce the implementation ...

ABSTRACT: The effects of tributyltin (TBT) and dibutyltin (DBT) on the hemocyte functions of the blue mussel Mytilus edulis were investigated in 2 separate experiments at 2 different cold periods of ...